Inovio Pharmaceuticals (INO) Stock Forecast for 2025, 2026, 2027. Sell or Buy Prediction







Understanding Accounting and Bookkeeping Services for Business Success

June 10, 2025 Understanding Accounting and Bookkeeping Services for Business Success

Every successful business relies on accurate financial records. From managing cash flow to ensuring compliance with tax regulations, reliable accounting and bookkeeping services…
How much does a Turkish passport cost?

May 27, 2025 How much does a Turkish passport cost?

Turkish citizenship comes with numerous benefits. Once granted, a foreigner can enter 126 countries visa-free, enjoy high-quality healthcare and favorable tax regimes, and…
How Measurement and Mix Modeling Drive Better Business Decisions

May 22, 2025 How Measurement and Mix Modeling Drive Better Business Decisions

In today’s data-driven business landscape, the ability to accurately measure and optimize marketing efforts has become a critical competitive advantage. As marketing evolves,…
Are you making these mistakes when analyzing candlestick patterns?

May 22, 2025 Are you making these mistakes when analyzing candlestick patterns?

Trading is a very popular endeavor these days, and for good reason, as it is widely accessible and allows individuals to generate additional…
Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

April 23, 2025 Oleksandr Orlovskyi: Reviews, Biography, and All About Cryptocurrency

What defines a successful crypto expert? The amount of money earned, the number of luxury cars and international real estate? The presence of…

Inovio Pharmaceuticals (INO) Stock Forecast for 2025, 2026, 2027. Sell or Buy?

Updated: June 22, 2025 (02:54)

Sector: Healthcare

The share price of Inovio Pharmaceuticals, Inc. (INO) now

Latest session on the 20th of June for
Inovio Pharmaceuticals, Inc. is positive
Trading Volume: 773569
Open: 1.97 /  High: 1.97 /  Low: 1.88
Current value: $1.96
What analysts predict: $8
52-week High/Low: $12.33 / $1.42
50-Day Moving Average: $1.827 — support level today
200-Day Moving Average: $3.596 — resistance level today

Are you interested in Inovio Pharmaceuticals, Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Inovio Pharmaceuticals stock price in 2025, 2026, 2027. How much will one Inovio Pharmaceuticals share be worth in 2025 - 2027?

When should I take profit in Inovio Pharmaceuticals stock? When should I record a loss on Inovio Pharmaceuticals stock? What are analysts' forecasts for Inovio Pharmaceuticals stock? What is the future of Inovio Pharmaceuticals stock? We forecast Inovio Pharmaceuticals stock performance using neural networks based on historical data on Inovio Pharmaceuticals stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account.

Inovio Pharmaceuticals stock prediction results are shown below and presented in the form of graphs, tables and text information, divided into time intervals. (Next month, 2025, 2026, 2027, and ) The final quotes of the instrument at the close of the previous trading day are a signal to adjust the forecasts for Inovio Pharmaceuticals shares. This happens once a day.


Historical and forecast chart of Inovio Pharmaceuticals stock

The chart below shows the historical price of Inovio Pharmaceuticals stock and a prediction chart for the next month. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the Inovio Pharmaceuticals stock price can be found in the table below.

Long-term forecasts by years.

Inovio Pharmaceuticals, Inc. a biotechnology company specializing in the discovery, development and commercialization of DNA drugs to treat, cure and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. Its SynCon immunotherapy design has the ability to disrupt the immune system’s tolerance to cancer cells and facilitate the cross-protection of strains against unrivaled and matched pathogens. The company participates in the conduct and planning of clinical trials of its DNA drugs for the treatment of HPV-associated cancers, including dysplasia of the cervix, vulva and anus; HPV-associated cancers, including cancers of the head and neck, cervix, anal canal, penis, vulva, and vagina; other HPV-associated diseases such as recurrent respiratory papillomatosis; glioblastoma multiforme; prostate cancer; HIV; Ebola; Middle East respiratory syndrome (MERS); Lassa fever; Zika virus; and the COVID-19 virus (coronavirus). Its partners and employees are ApolloBio Corp., AstraZeneca PLC or AstraZeneca, Beijing Advaccine Biotechnology Co., Bill & Melinda Gates Foundation, Epidemic Preparedness Innovation Coalition (EPIR), Defense Advanced Research Projects Agency (DARPA), Life Sciences GeneOne. HIV Vaccine Threat Reduction Forensic Network, Defense Consortium Medical Weapons Agency (GCDC), National Cancer Institute, National Institutes of Health, National Institute of Allergic and Infectious Diseases, Life Science Plumb Line, Regeneron Pharmaceuticals, Roche / Genentech, University Pennsylvania, University. Walter Reed Army Research Institute and Wistar Institute. The company also has an agreement with Richter-Helm BioLogics GmbH & Co. KG to support the INO-4800 DNA research vaccine currently in Phase I of the COVID-19 clinical trials; and partnerships with the International Vaccine Institute and Seoul National University Hospital. The company was founded in 1979 and is headquartered in Plymouth Meeting, Pennsylvania.

Trending Themes in the Healthcare Sector

Inovio Pharmaceuticals daily forecast for a month

Date Target Pes. Opt. Vol., %
Jun 23 2.04 2.01 2.12 5.69
Jun 24 2.09 2.02 2.17 7.35
Jun 25 2.07 2.03 2.10 3.57
Jun 26 2.10 2.07 2.13 3.09
Jun 27 2.07 2.02 2.15 6.67
Jun 28 2.14 2.06 2.19 6.55
Jun 29 2.18 2.09 2.22 5.93
Jun 30 2.16 2.08 2.23 7.13
Jul 01 2.24 2.20 2.30 4.43
Jul 02 2.20 2.12 2.28 7.84
Jul 03 2.25 2.18 2.33 6.88
Jul 04 2.33 2.26 2.38 5.59
Jul 05 2.38 2.33 2.42 3.89
Jul 06 2.43 2.36 2.46 4.22
Jul 07 2.51 2.48 2.58 4.25
Jul 08 2.62 2.55 2.70 5.85
Jul 09 2.57 2.47 2.61 5.61
Jul 10 2.51 2.47 2.55 3.20
Jul 11 2.39 2.30 2.42 5.14
Jul 12 2.36 2.29 2.43 5.99
Jul 13 2.39 2.31 2.47 7.29
Jul 14 2.27 2.18 2.33 6.87
Jul 15 2.24 2.21 2.26 2.23
Jul 16 2.26 2.18 2.32 6.22
Jul 17 2.26 2.23 2.35 5.27
Jul 18 2.26 2.18 2.33 7.17
Jul 19 2.20 2.12 2.26 6.87
Jul 20 2.22 2.17 2.25 3.58
Jul 21 2.20 2.13 2.28 7.39
Jul 22 2.15 2.11 2.20 4.18

Inovio Pharmaceuticals Daily Price Targets


Inovio Pharmaceuticals Stock Forecast 06-23-2025.

Forecast target price for 06-23-2025: $2.04.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 5.384%.
Pessimistic target level: 2.01
Optimistic target level: 2.12

Inovio Pharmaceuticals Stock Forecast 06-24-2025.

Forecast target price for 06-24-2025: $2.09.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 6.843%.
Pessimistic target level: 2.02
Optimistic target level: 2.17

Inovio Pharmaceuticals Stock Forecast 06-25-2025.

Forecast target price for 06-25-2025: $2.07.
Negative dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 3.450%.
Pessimistic target level: 2.03
Optimistic target level: 2.10

Inovio Pharmaceuticals Stock Forecast 06-26-2025.

Forecast target price for 06-26-2025: $2.10.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 3.000%.
Pessimistic target level: 2.07
Optimistic target level: 2.13

Inovio Pharmaceuticals Stock Forecast 06-27-2025.

Forecast target price for 06-27-2025: $2.07.
Negative dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 6.256%.
Pessimistic target level: 2.02
Optimistic target level: 2.15

Inovio Pharmaceuticals Stock Forecast 06-28-2025.

Forecast target price for 06-28-2025: $2.14.
Positive dynamics for Inovio Pharmaceuticals shares will prevail with possible volatility of 6.149%.
Pessimistic target level: 2.06
Optimistic target level: 2.19

INO (INO) Monthly Stock Prediction for 2025

Month Target Pes. Opt. Vol., %
Jul. 2.03 1.89 2.09 9.69
Jul. 2.03 1.88 2.14 11.97
Aug. 1.96 1.81 2.09 13.47
Oct. 2.05 2.00 2.12 5.72
Oct. 1.85 1.78 1.93 7.75
Dec. 1.99 1.94 2.10 7.40
Dec. 1.93 1.79 2.03 12.07

Inovio Pharmaceuticals forecast for this year


Inovio Pharmaceuticals Stock Prediction for Jul 2025

An uptrend is forecast for this month with an optimal target price of $2.02989. Pessimistic: $1.89. Optimistic: $2.09


Inovio Pharmaceuticals Stock Prediction for Jul 2025

An downtrend is forecast for this month with an optimal target price of $2.02989. Pessimistic: $1.88. Optimistic: $2.14


Inovio Pharmaceuticals Stock Prediction for Aug 2025

An downtrend is forecast for this month with an optimal target price of $1.95884. Pessimistic: $1.81. Optimistic: $2.09


Inovio Pharmaceuticals Stock Prediction for Oct 2025

An uptrend is forecast for this month with an optimal target price of $2.05287. Pessimistic: $2.00. Optimistic: $2.12


Inovio Pharmaceuticals Stock Prediction for Oct 2025

An downtrend is forecast for this month with an optimal target price of $1.84963. Pessimistic: $1.78. Optimistic: $1.93


Inovio Pharmaceuticals Stock Prediction for Dec 2025

An uptrend is forecast for this month with an optimal target price of $1.99206. Pessimistic: $1.94. Optimistic: $2.10


Inovio Pharmaceuticals Stock Prediction for Dec 2025

An downtrend is forecast for this month with an optimal target price of $1.93429. Pessimistic: $1.79. Optimistic: $2.03



Inovio Pharmaceuticals (INO) Monthly Stock Prediction for 2026

Month Target Pes. Opt. Vol., %
Jan 1.93 1.81 2.02 10.30
Mar 1.96 1.81 2.05 11.30
Mar 1.93 1.80 1.97 8.82
May 1.87 1.74 1.94 10.32
May 1.83 1.70 1.97 14.13
Jul 1.98 1.84 2.08 11.60
Jul 2.17 2.03 2.27 10.33
Aug 2.18 2.13 2.34 9.10
Oct 2.27 2.17 2.40 9.53
Oct 2.31 2.20 2.41 8.64
Dec 2.21 2.13 2.36 9.82
Dec 2.38 2.22 2.53 12.22

Inovio Pharmaceuticals (INO) Monthly Stock Prediction for 2027

Month Target Pes. Opt. Vol., %
Jan 2.43 2.35 2.60 9.53
Mar 2.47 2.35 2.56 7.93
Mar 2.35 2.27 2.50 9.39
May 2.46 2.34 2.57 8.99
May 2.60 2.50 2.67 6.23
Jul 2.82 2.75 2.98 7.77
Jul 2.74 2.56 2.85 10.28
Aug 2.99 2.76 3.10 10.82
Oct 3.01 2.89 3.16 8.59
Oct 2.81 2.60 2.92 10.97
Dec 2.89 2.78 3.05 8.89
Dec 2.70 2.63 2.80 5.97

Inovio Pharmaceuticals information and performance

Inovio Pharmaceuticals Address

10480 WATERIDGE CIRCLE, SAN DIEGO, CA, US

Market Capitalization: 78 116 000 $

Market capitalization of the Inovio Pharmaceuticals, Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of INO shares in the company outstanding by the market price of one share.

EBITDA: -104 265 440 $

EBITDA of Inovio Pharmaceuticals is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: N/A

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -3.35

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: 0.14
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 57.43

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.094

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 36674400

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

FAQ (Frequently Asked Questions about Inovio Pharmaceuticals Stock)

Should I Buy Inovio Pharmaceuticals Shares in 2025 year?

The maximum forecasted share price for next year is $2.38, which is $0.42 higher than the current stock price. By investing in Inovio Pharmaceuticals shares today for a one-year period, you could achieve a profit of 21.44%. With an investment horizon of up to two years, the target share price is $3.01. resulting in a profit of 53.71% ($1.05 per share).

Does Inovio Pharmaceuticals pay dividends?

No, it does not

Which economic sector do Inovio Pharmaceuticals's shares belong to?

Inovio Pharmaceuticals's shares belong to the "Healthcare" sector of economic.

Which other securities belong to the same sector as Inovio Pharmaceuticals's shares?

You can view all the stocks that are part of the same sector as Inovio Pharmaceuticals's shares in the Healthcare section.


Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.